Safety and effectiveness of Neuroform Atlas stent-assisted coil embolization for ruptured intracranial aneurysms.

Journal of cerebrovascular and endovascular neurosurgery Pub Date : 2024-10-11 DOI:10.7461/jcen.2024.E2024.04.006

Kyu Sik Heo, Jung Ho Ko

{"title":"Safety and effectiveness of Neuroform Atlas stent-assisted coil embolization for ruptured intracranial aneurysms.","authors":"Kyu Sik Heo, Jung Ho Ko","doi":"10.7461/jcen.2024.E2024.04.006","DOIUrl":null,"url":null,"abstract":"Objective: The treatment outcomes of ruptured intracranial aneurysms using the Neuroform Atlas stent were evaluated.Methods: This study represents a retrospective review that included patients who underwent endovascular treatment for ruptured aneurysms at a single institution. Between January 2018 and September 2022, endovascular treatments including simple coiling or Neuroform Atlas stent-assisted coil embolization were performed in 191 patients with ruptured intracranial aneurysms.Results: Intraprocedural rupture was observed in 11 (8.7%) patients in the Simple Coiling (SC) group, which was slightly higher than that in 4 (6.3%) patients in the Neuroform Atlas stent-assisted coiling (NASAC) group (p=0.241). However, Thromboembolic event (TEE) was slightly more prevalent in the NASAC group, with 4 (6.3%) cases as compared to the 5 (3.9%) cases in the SC group (p=0.235). The retreatment rate was slightly higher in the SC group, with 19 (26.4%) patients as compared to the 10 patients (22.2%) in the NASAC group (p=0.342).Conclusions: The use of the Neuroform Atlas stent (NAS) for ruptured aneurysms might be safe and effective.","PeriodicalId":94072,"journal":{"name":"Journal of cerebrovascular and endovascular neurosurgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cerebrovascular and endovascular neurosurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7461/jcen.2024.E2024.04.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The treatment outcomes of ruptured intracranial aneurysms using the Neuroform Atlas stent were evaluated.

Methods: This study represents a retrospective review that included patients who underwent endovascular treatment for ruptured aneurysms at a single institution. Between January 2018 and September 2022, endovascular treatments including simple coiling or Neuroform Atlas stent-assisted coil embolization were performed in 191 patients with ruptured intracranial aneurysms.

Results: Intraprocedural rupture was observed in 11 (8.7%) patients in the Simple Coiling (SC) group, which was slightly higher than that in 4 (6.3%) patients in the Neuroform Atlas stent-assisted coiling (NASAC) group (p=0.241). However, Thromboembolic event (TEE) was slightly more prevalent in the NASAC group, with 4 (6.3%) cases as compared to the 5 (3.9%) cases in the SC group (p=0.235). The retreatment rate was slightly higher in the SC group, with 19 (26.4%) patients as compared to the 10 patients (22.2%) in the NASAC group (p=0.342).

Conclusions: The use of the Neuroform Atlas stent (NAS) for ruptured aneurysms might be safe and effective.

查看原文本刊更多论文

Neuroform Atlas 支架辅助线圈栓塞治疗颅内动脉瘤破裂的安全性和有效性。

目的：评估使用 Neuroform Atlas 支架治疗颅内动脉瘤破裂的疗效：评估使用 Neuroform Atlas 支架治疗颅内动脉瘤破裂的疗效：本研究是一项回顾性研究，纳入了在一家机构接受血管内治疗的动脉瘤破裂患者。2018年1月至2022年9月期间，对191例颅内动脉瘤破裂患者进行了血管内治疗，包括简单的卷曲或Neuroform Atlas支架辅助的线圈栓塞：简单卷曲（SC）组有11例（8.7%）患者出现序贯内破裂，略高于Neuroform Atlas支架辅助卷曲（NASAC）组的4例（6.3%）（P=0.241）。然而，血栓栓塞事件（TEE）在 NASAC 组中发生率略高，为 4 例（6.3%），而在 SC 组中为 5 例（3.9%）（P=0.235）。SC组的再治疗率略高，为19例（26.4%），而NASAC组为10例（22.2%）（P=0.342）：结论：使用 Neuroform Atlas 支架（NAS）治疗破裂动脉瘤可能是安全有效的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of cerebrovascular and endovascular neurosurgery

CiteScore

1.10

自引率

0.00%

发文量